Yu-Kyong Shin Selected Research

Yu-Kyong Shin Research Topics

3	Type 2 Diabetes Mellitus (MODY) 10/2013 - 01/2008
2	Body Weight (Weight, Body) 03/2021 - 05/2010
2	Infections 02/2006 - 10/2005
1	Overweight 01/2022
1	Obesity 01/2022
1	Hyperlipidemias (Hyperlipidemia) 03/2021
1	Periodontitis 06/2018
1	Inflammation (Inflammations) 06/2018
1	Alveolar Bone Loss 06/2018
1	Wounds and Injuries (Trauma) 01/2018
1	Immune System Diseases (Immune Disorders) 02/2017
1	Prediabetic State (Prediabetes) 10/2013
1	Insulin Resistance 10/2013
1	Weight Gain 10/2013
1	Hyperglycemia 06/2009
1	Bites and Stings (Sting) 06/2009
1	Metabolic Diseases (Metabolic Disease) 01/2008

3	Insulin (Novolin)FDA Link 03/2021 - 01/2008
3	Glucose (Dextrose)FDA LinkGeneric 10/2013 - 01/2008
2	Hormones (Hormone)IBA 03/2021 - 05/2010
2	Proteins (Proteins, Gene)FDA Link 02/2006 - 10/2005
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 01/2022
1	TabletsIBA 01/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 03/2021
1	LipidsIBA 03/2021
1	LeptinIBA 03/2021
1	oxidized low density lipoproteinIBA 03/2021
1	CholesterolIBA 03/2021
1	Biomarkers (Surrogate Marker)IBA 06/2018
1	trachelosideIBA 01/2018
1	Therapeutic UsesIBA 02/2017
1	Sirtuin 1IBA 10/2013
1	SugarsIBA 10/2013
1	ResveratrolIBA 10/2013
1	Saline SolutionIBA 06/2009
1	Acetaminophen (Paracetamol)FDA LinkGeneric 06/2009
1	Glucagon-Like Peptides (Enteroglucagon)IBA 06/2009
1	gastric inhibitory polypeptide receptorIBA 06/2009
1	Peptides (Polypeptides)IBA 06/2009
1	Glucagon-Like Peptide 1 (GLP 1)IBA 06/2009
1	Blood Glucose (Blood Sugar)IBA 01/2008

3	Oral Administration 01/2022 - 06/2018
1	Ligation 06/2018